Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gusacitinib in chronic hand eczema
NCT03728504Phase 2Completed
- Sponsor
- Asana BioSciences, LLC
- Start
- Jan 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of gusacitinib in chronic hand eczema (CHE), sponsored by Asana BioSciences, LLC. Started Jan 2019; status: completed.
02
Drugs
gusacitinib
03
Conditions
chronic hand eczema (CHE)
Beyond the preview
Go deeper on NCT03728504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03728504.